Certifications 2

MODEL COLOR
Safety data sheet
According to 1907/2006/EC (REACH), 2015/830/EU
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
1.1
Product identifier:
MODEL COLOR
1.2
Relevant identified uses of the substance or mixture and uses advised against:
Relevant uses: Paint
Uses advised against: All uses not specified in this section or in section 7.3
1.3
Details of the supplier of the safety data sheet:
ACRYLICOS VALLEJO, S.L.
Pol. Ind. Sant Jordi - C/ Eusebio Millán, 14
08800 Vilanova i La Geltrú - Barcelona - Spain
Phone.: [phone] - Fax: [phone]
[e-mail]
www.acrylicosvallejo.com
1.4
Emergency telephone number:
[phone] (9:00 - 17:00)
SECTION 2: HAZARDS IDENTIFICATION
2.1
Classification of the substance or mixture:
CLP Regulation (EC) No 1272/2008:
The product is not classified as hazardous according to CLP Regulation (EC) No 1272/2008.
2.2
Label elements:
CLP Regulation (EC) No 1272/2008:
None
2.3
Other hazards:
Product fails to meet PBT/vPvB criteria
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.1
Substance:
Non-applicable
3.2
Mixture:
Chemical description:
Mixture composed of additives, pigments and resins
Components:
None of the substances contained in the mixture are above the values fixed in Annex II of Regulation (EC) No 1907/2006
SECTION 4: FIRST AID MEASURES
4.1
Description of first aid measures:
Consult a doctor in case of discomfort showing the SDS for the product.
By inhalation:
In case of symptoms, move the person affected into fresh air.
By skin contact:
In case of contact it is recommended to clean the affected area thoroughly with water and neutral soap. In case of changes to
the skin (stinging, redness, rashes, blisters,…), seek medical advice with this Safety data Sheet
By eye contact:
Rinse with water until the product has been eliminated. In case of problems, consult a doctor showing the SDS for the product.
By ingestion/aspiration:
In case of consumption in large quantities, it is recommended to seek medical assistance.
4.2
Most important symptoms and effects, both acute and delayed:
Acute and delayed effects are indicated in sections 2 and 11.
4.3
Indication of any immediate medical attention and special treatment needed:
Page 1/8
Date of compilation: 08/06/2015 Version: 1
- CONTINUED ON NEXT PAGE -